Form 4: Glaukos Corp President & COO Joseph E. Gilliam Reports Stock Option Exercise and Sale

Joseph E. Gilliam, President & COO of Glaukos Corporation, exercised stock options and sold shares of common stock on April 8, 2024, according to a Form 4 filing with the SEC.

Summary

• On April 8, 2024, Joseph E. Gilliam, the President & COO of Glaukos Corporation, exercised stock options to acquire 59,801 shares of common stock at a price of $41.69 per share.
• Following the exercise, Gilliam sold a total of 59,801 shares in multiple transactions at weighted average prices of $99.64, $100.52, $101.28, and $102.13.
• These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 7, 2023.
• After these transactions, Gilliam directly owns 101,845 shares of Glaukos Corporation common stock, which includes 76,419 unvested restricted stock units.
• The filing also notes an adjustment of 15,872 stock options due to a domestic relations order related to a marital dissolution.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it's a standard report of insider trading activity under a pre-existing trading plan. There's no indication of positive or negative implications for the company.

Industry Context

This filing is a routine disclosure of insider transactions. It's common for executives to exercise stock options and sell shares, especially under pre-arranged trading plans like Rule 10b5-1, which allows insiders to trade without being accused of acting on non-public information.

Comparison to Industry Standards

• Insider transactions are a normal part of corporate governance.
• Companies like Alcon, Johnson & Johnson, and Bausch + Lomb also have executives who regularly report similar transactions.
• The use of 10b5-1 plans is a common practice among executives to avoid accusations of insider trading.

Key Dates